Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: Cross-sectional Study of Vitamin B6 in Parkinson's Disease

View source ↗

Summary

A completed cross-sectional study investigated Vitamin B6 (pyridoxine) in Parkinson's disease, as reported by the University of Rochester.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin B6 (pyridoxine)

Snippet

Sponsor: University of Rochester | Conditions: Parkinson's Disease (PD) | Status: COMPLETED